We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
Increased
6
Reduced
3
Closed
920

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARGU
801
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
-477,246
Closed -$4.8M
COVA
802
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
-110,863
Closed -$1.1M
COLI
803
DELISTED
Colicity Inc. Class A Common Stock
COLI
-237,628
Closed -$2.34M
AGCB
804
DELISTED
Altimeter Growth Corp 2
AGCB
-331,212
Closed -$3.28M
FLYA
805
DELISTED
SOAR Technology Acquisition Corp.
FLYA
-802,480
Closed -$8.27M
RXRA
806
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
-477,247
Closed -$4.7M
VELOW
807
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
-70,512
Closed -$6K
VELO
808
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
-526,552
Closed -$5.18M
GLHA
809
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
-275,741
Closed -$2.71M
KLAQ
810
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
-427,526
Closed -$4.23M
KLAQW
811
DELISTED
KL Acquisition Corp Warrant
KLAQW
-112,473
Closed -$8K
BTRS
812
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
-3,203,681
Closed -$29.7M
POND
813
DELISTED
Angel Pond Holdings Corporation
POND
-468,407
Closed -$4.6M
AAQC
814
DELISTED
Accelerate Acquisition Corp
AAQC
-477,246
Closed -$4.69M
GHAC
815
DELISTED
Gaming & Hospitality Acquisition Corp. Class A Common Stock
GHAC
-379,815
Closed -$3.74M
GTPA
816
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
-467,890
Closed -$4.6M
GHACW
817
DELISTED
Gaming & Hospitality Acquisition Corp. Warrants
GHACW
-112,473
Closed -$6K
GTPB
818
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
-935,265
Closed -$9.18M
GSEV
819
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
-1,180,789
Closed -$11.6M
SPGS
820
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
-237,628
Closed -$2.34M
TSPQ
821
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
-239,156
Closed -$2.35M
AMPI
822
DELISTED
Advanced Merger Partners Inc
AMPI
-290,346
Closed -$2.86M
JOFFW
823
DELISTED
JOFF Fintech Acquisition Corp. Warrant
JOFFW
-418,571
Closed -$23K
JOFF
824
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
-238,558
Closed -$2.35M
KAHC
825
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
-354,298
Closed -$3.49M

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.